Global Contraceptives Market Size, Manufacturers, Opportunities and Forecast to 2030
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
According to APO Research, The global Contraceptives market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.
The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Contraceptives market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.
The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Contraceptives Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Contraceptives Sales Estimates and Forecasts (2019-2030)
1.3 Contraceptives Market by Type
1.3.1 Pills
1.3.2 Injectable
1.3.3 Condoms
1.3.4 Vaginal Rings
1.3.5 IUDs
1.3.6 Subdermal Implants
1.3.7 Others
1.4 Global Contraceptives Market Size by Type
1.4.1 Global Contraceptives Market Size Overview by Type (2019-2030)
1.4.2 Global Contraceptives Historic Market Size Review by Type (2019-2024)
1.4.3 Global Contraceptives Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Contraceptives Sales Breakdown by Type (2019-2024)
1.5.2 Europe Contraceptives Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Contraceptives Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Contraceptives Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Contraceptives Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Contraceptives Industry Trends
2.2 Contraceptives Industry Drivers
2.3 Contraceptives Industry Opportunities and Challenges
2.4 Contraceptives Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Contraceptives Revenue (2019-2024)
3.2 Global Top Players by Contraceptives Sales (2019-2024)
3.3 Global Top Players by Contraceptives Price (2019-2024)
3.4 Global Contraceptives Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Contraceptives Key Company Manufacturing Sites & Headquarters
3.6 Global Contraceptives Company, Product Type & Application
3.7 Global Contraceptives Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Contraceptives Market CR5 and HHI
3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2023
3.8.3 2023 Contraceptives Tier 1, Tier 2, and Tier
4 CONTRACEPTIVES REGIONAL STATUS AND OUTLOOK
4.1 Global Contraceptives Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Contraceptives Historic Market Size by Region
4.2.1 Global Contraceptives Sales in Volume by Region (2019-2024)
4.2.2 Global Contraceptives Sales in Value by Region (2019-2024)
4.2.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Contraceptives Forecasted Market Size by Region
4.3.1 Global Contraceptives Sales in Volume by Region (2025-2030)
4.3.2 Global Contraceptives Sales in Value by Region (2025-2030)
4.3.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 CONTRACEPTIVES BY APPLICATION
5.1 Contraceptives Market by End User
5.1.1 15–24 years
5.1.2 25–34 years
5.1.3 35–44 years
5.1.4 Above 44 years
5.2 Global Contraceptives Market Size by End User
5.2.1 Global Contraceptives Market Size Overview by Application (2019-2030)
5.2.2 Global Contraceptives Historic Market Size Review by Application (2019-2024)
5.2.3 Global Contraceptives Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by End User
5.3.1 North America Contraceptives Sales Breakdown by End User (2019-2024)
5.3.2 Europe Contraceptives Sales Breakdown by End User (2019-2024)
5.3.3 Asia-Pacific Contraceptives Sales Breakdown by End User (2019-2024)
5.3.4 Latin America Contraceptives Sales Breakdown by End User (2019-2024)
5.3.5 Middle East and Africa Contraceptives Sales Breakdown by End User (2019-2024)
6 COMPANY PROFILES
6.1 Bayer AG
6.1.1 Bayer AG Comapny Information
6.1.2 Bayer AG Business Overview
6.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer AG Contraceptives Product Portfolio
6.1.5 Bayer AG Recent Developments
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Comapny Information
6.2.2 Pfizer, Inc Business Overview
6.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer, Inc Contraceptives Product Portfolio
6.2.5 Pfizer, Inc Recent Developments
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Comapny Information
6.3.2 Teva Pharmaceutical Industries Ltd Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
6.4 Merck & Co., Inc
6.4.1 Merck & Co., Inc Comapny Information
6.4.2 Merck & Co., Inc Business Overview
6.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc Contraceptives Product Portfolio
6.4.5 Merck & Co., Inc Recent Developments
6.5 Actavis, Inc.
6.5.1 Actavis, Inc. Comapny Information
6.5.2 Actavis, Inc. Business Overview
6.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actavis, Inc. Contraceptives Product Portfolio
6.5.5 Actavis, Inc. Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Comapny Information
6.6.2 Johnson & Johnson Business Overview
6.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Contraceptives Product Portfolio
6.6.5 Johnson & Johnson Recent Developments
6.7 Gedeon Richter
6.7.1 Gedeon Richter Comapny Information
6.7.2 Gedeon Richter Business Overview
6.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Gedeon Richter Contraceptives Product Portfolio
6.7.5 Gedeon Richter Recent Developments
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Comapny Information
6.8.2 Novo Nordisk A/S Business Overview
6.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments
6.9 ZiZhu
6.9.1 ZiZhu Comapny Information
6.9.2 ZiZhu Business Overview
6.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZiZhu Contraceptives Product Portfolio
6.9.5 ZiZhu Recent Developments
6.10 Baijingyu
6.10.1 Baijingyu Comapny Information
6.10.2 Baijingyu Business Overview
6.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baijingyu Contraceptives Product Portfolio
6.10.5 Baijingyu Recent Developments
6.11 Huazhong
6.11.1 Huazhong Comapny Information
6.11.2 Huazhong Business Overview
6.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huazhong Contraceptives Product Portfolio
6.11.5 Huazhong Recent Developments
6.12 Sine
6.12.1 Sine Comapny Information
6.12.2 Sine Business Overview
6.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sine Contraceptives Product Portfolio
6.12.5 Sine Recent Developments
6.13 Reckitt
6.13.1 Reckitt Comapny Information
6.13.2 Reckitt Business Overview
6.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Reckitt Contraceptives Product Portfolio
6.13.5 Reckitt Recent Developments
6.14 AbbVie
6.14.1 AbbVie Comapny Information
6.14.2 AbbVie Business Overview
6.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AbbVie Contraceptives Product Portfolio
6.14.5 AbbVie Recent Developments
6.15 Church & Dwight
6.15.1 Church & Dwight Comapny Information
6.15.2 Church & Dwight Business Overview
6.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Church & Dwight Contraceptives Product Portfolio
6.15.5 Church & Dwight Recent Developments
6.16 The Cooper Companies
6.16.1 The Cooper Companies Comapny Information
6.16.2 The Cooper Companies Business Overview
6.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.16.4 The Cooper Companies Contraceptives Product Portfolio
6.16.5 The Cooper Companies Recent Developments
6.17 TherapeuticsMD
6.17.1 TherapeuticsMD Comapny Information
6.17.2 TherapeuticsMD Business Overview
6.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.17.4 TherapeuticsMD Contraceptives Product Portfolio
6.17.5 TherapeuticsMD Recent Developments
6.18 Afaxys
6.18.1 Afaxys Comapny Information
6.18.2 Afaxys Business Overview
6.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Afaxys Contraceptives Product Portfolio
6.18.5 Afaxys Recent Developments
6.19 Mithra Pharmaceuticals
6.19.1 Mithra Pharmaceuticals Comapny Information
6.19.2 Mithra Pharmaceuticals Business Overview
6.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
6.19.5 Mithra Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Contraceptives Sales by Country
7.1.1 North America Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Contraceptives Sales by Country (2019-2024)
7.1.3 North America Contraceptives Sales Forecast by Country (2025-2030)
7.2 North America Contraceptives Market Size by Country
7.2.1 North America Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Contraceptives Market Size by Country (2019-2024)
7.2.3 North America Contraceptives Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Contraceptives Sales by Country
8.1.1 Europe Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Contraceptives Sales by Country (2019-2024)
8.1.3 Europe Contraceptives Sales Forecast by Country (2025-2030)
8.2 Europe Contraceptives Market Size by Country
8.2.1 Europe Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Contraceptives Market Size by Country (2019-2024)
8.2.3 Europe Contraceptives Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Contraceptives Sales by Country
9.1.1 Asia-Pacific Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Contraceptives Sales by Country (2019-2024)
9.1.3 Asia-Pacific Contraceptives Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Contraceptives Market Size by Country
9.2.1 Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Contraceptives Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Contraceptives Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Contraceptives Sales by Country
10.1.1 Latin America Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Contraceptives Sales by Country (2019-2024)
10.1.3 Latin America Contraceptives Sales Forecast by Country (2025-2030)
10.2 Latin America Contraceptives Market Size by Country
10.2.1 Latin America Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Contraceptives Market Size by Country (2019-2024)
10.2.3 Latin America Contraceptives Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Contraceptives Sales by Country
11.1.1 Middle East and Africa Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Contraceptives Sales by Country (2019-2024)
11.1.3 Middle East and Africa Contraceptives Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Contraceptives Market Size by Country
11.2.1 Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Contraceptives Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Contraceptives Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Contraceptives Value Chain Analysis
12.1.1 Contraceptives Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Contraceptives Production Mode & Process
12.2 Contraceptives Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Contraceptives Distributors
12.2.3 Contraceptives Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Contraceptives Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Contraceptives Sales Estimates and Forecasts (2019-2030)
1.3 Contraceptives Market by Type
1.3.1 Pills
1.3.2 Injectable
1.3.3 Condoms
1.3.4 Vaginal Rings
1.3.5 IUDs
1.3.6 Subdermal Implants
1.3.7 Others
1.4 Global Contraceptives Market Size by Type
1.4.1 Global Contraceptives Market Size Overview by Type (2019-2030)
1.4.2 Global Contraceptives Historic Market Size Review by Type (2019-2024)
1.4.3 Global Contraceptives Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Contraceptives Sales Breakdown by Type (2019-2024)
1.5.2 Europe Contraceptives Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Contraceptives Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Contraceptives Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Contraceptives Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Contraceptives Industry Trends
2.2 Contraceptives Industry Drivers
2.3 Contraceptives Industry Opportunities and Challenges
2.4 Contraceptives Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Contraceptives Revenue (2019-2024)
3.2 Global Top Players by Contraceptives Sales (2019-2024)
3.3 Global Top Players by Contraceptives Price (2019-2024)
3.4 Global Contraceptives Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Contraceptives Key Company Manufacturing Sites & Headquarters
3.6 Global Contraceptives Company, Product Type & Application
3.7 Global Contraceptives Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Contraceptives Market CR5 and HHI
3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2023
3.8.3 2023 Contraceptives Tier 1, Tier 2, and Tier
4 CONTRACEPTIVES REGIONAL STATUS AND OUTLOOK
4.1 Global Contraceptives Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Contraceptives Historic Market Size by Region
4.2.1 Global Contraceptives Sales in Volume by Region (2019-2024)
4.2.2 Global Contraceptives Sales in Value by Region (2019-2024)
4.2.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Contraceptives Forecasted Market Size by Region
4.3.1 Global Contraceptives Sales in Volume by Region (2025-2030)
4.3.2 Global Contraceptives Sales in Value by Region (2025-2030)
4.3.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 CONTRACEPTIVES BY APPLICATION
5.1 Contraceptives Market by End User
5.1.1 15–24 years
5.1.2 25–34 years
5.1.3 35–44 years
5.1.4 Above 44 years
5.2 Global Contraceptives Market Size by End User
5.2.1 Global Contraceptives Market Size Overview by Application (2019-2030)
5.2.2 Global Contraceptives Historic Market Size Review by Application (2019-2024)
5.2.3 Global Contraceptives Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by End User
5.3.1 North America Contraceptives Sales Breakdown by End User (2019-2024)
5.3.2 Europe Contraceptives Sales Breakdown by End User (2019-2024)
5.3.3 Asia-Pacific Contraceptives Sales Breakdown by End User (2019-2024)
5.3.4 Latin America Contraceptives Sales Breakdown by End User (2019-2024)
5.3.5 Middle East and Africa Contraceptives Sales Breakdown by End User (2019-2024)
6 COMPANY PROFILES
6.1 Bayer AG
6.1.1 Bayer AG Comapny Information
6.1.2 Bayer AG Business Overview
6.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer AG Contraceptives Product Portfolio
6.1.5 Bayer AG Recent Developments
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Comapny Information
6.2.2 Pfizer, Inc Business Overview
6.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer, Inc Contraceptives Product Portfolio
6.2.5 Pfizer, Inc Recent Developments
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Comapny Information
6.3.2 Teva Pharmaceutical Industries Ltd Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
6.4 Merck & Co., Inc
6.4.1 Merck & Co., Inc Comapny Information
6.4.2 Merck & Co., Inc Business Overview
6.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc Contraceptives Product Portfolio
6.4.5 Merck & Co., Inc Recent Developments
6.5 Actavis, Inc.
6.5.1 Actavis, Inc. Comapny Information
6.5.2 Actavis, Inc. Business Overview
6.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actavis, Inc. Contraceptives Product Portfolio
6.5.5 Actavis, Inc. Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Comapny Information
6.6.2 Johnson & Johnson Business Overview
6.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Contraceptives Product Portfolio
6.6.5 Johnson & Johnson Recent Developments
6.7 Gedeon Richter
6.7.1 Gedeon Richter Comapny Information
6.7.2 Gedeon Richter Business Overview
6.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Gedeon Richter Contraceptives Product Portfolio
6.7.5 Gedeon Richter Recent Developments
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Comapny Information
6.8.2 Novo Nordisk A/S Business Overview
6.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments
6.9 ZiZhu
6.9.1 ZiZhu Comapny Information
6.9.2 ZiZhu Business Overview
6.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZiZhu Contraceptives Product Portfolio
6.9.5 ZiZhu Recent Developments
6.10 Baijingyu
6.10.1 Baijingyu Comapny Information
6.10.2 Baijingyu Business Overview
6.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baijingyu Contraceptives Product Portfolio
6.10.5 Baijingyu Recent Developments
6.11 Huazhong
6.11.1 Huazhong Comapny Information
6.11.2 Huazhong Business Overview
6.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huazhong Contraceptives Product Portfolio
6.11.5 Huazhong Recent Developments
6.12 Sine
6.12.1 Sine Comapny Information
6.12.2 Sine Business Overview
6.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sine Contraceptives Product Portfolio
6.12.5 Sine Recent Developments
6.13 Reckitt
6.13.1 Reckitt Comapny Information
6.13.2 Reckitt Business Overview
6.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Reckitt Contraceptives Product Portfolio
6.13.5 Reckitt Recent Developments
6.14 AbbVie
6.14.1 AbbVie Comapny Information
6.14.2 AbbVie Business Overview
6.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AbbVie Contraceptives Product Portfolio
6.14.5 AbbVie Recent Developments
6.15 Church & Dwight
6.15.1 Church & Dwight Comapny Information
6.15.2 Church & Dwight Business Overview
6.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Church & Dwight Contraceptives Product Portfolio
6.15.5 Church & Dwight Recent Developments
6.16 The Cooper Companies
6.16.1 The Cooper Companies Comapny Information
6.16.2 The Cooper Companies Business Overview
6.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.16.4 The Cooper Companies Contraceptives Product Portfolio
6.16.5 The Cooper Companies Recent Developments
6.17 TherapeuticsMD
6.17.1 TherapeuticsMD Comapny Information
6.17.2 TherapeuticsMD Business Overview
6.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.17.4 TherapeuticsMD Contraceptives Product Portfolio
6.17.5 TherapeuticsMD Recent Developments
6.18 Afaxys
6.18.1 Afaxys Comapny Information
6.18.2 Afaxys Business Overview
6.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Afaxys Contraceptives Product Portfolio
6.18.5 Afaxys Recent Developments
6.19 Mithra Pharmaceuticals
6.19.1 Mithra Pharmaceuticals Comapny Information
6.19.2 Mithra Pharmaceuticals Business Overview
6.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
6.19.5 Mithra Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Contraceptives Sales by Country
7.1.1 North America Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Contraceptives Sales by Country (2019-2024)
7.1.3 North America Contraceptives Sales Forecast by Country (2025-2030)
7.2 North America Contraceptives Market Size by Country
7.2.1 North America Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Contraceptives Market Size by Country (2019-2024)
7.2.3 North America Contraceptives Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Contraceptives Sales by Country
8.1.1 Europe Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Contraceptives Sales by Country (2019-2024)
8.1.3 Europe Contraceptives Sales Forecast by Country (2025-2030)
8.2 Europe Contraceptives Market Size by Country
8.2.1 Europe Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Contraceptives Market Size by Country (2019-2024)
8.2.3 Europe Contraceptives Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Contraceptives Sales by Country
9.1.1 Asia-Pacific Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Contraceptives Sales by Country (2019-2024)
9.1.3 Asia-Pacific Contraceptives Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Contraceptives Market Size by Country
9.2.1 Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Contraceptives Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Contraceptives Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Contraceptives Sales by Country
10.1.1 Latin America Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Contraceptives Sales by Country (2019-2024)
10.1.3 Latin America Contraceptives Sales Forecast by Country (2025-2030)
10.2 Latin America Contraceptives Market Size by Country
10.2.1 Latin America Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Contraceptives Market Size by Country (2019-2024)
10.2.3 Latin America Contraceptives Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Contraceptives Sales by Country
11.1.1 Middle East and Africa Contraceptives Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Contraceptives Sales by Country (2019-2024)
11.1.3 Middle East and Africa Contraceptives Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Contraceptives Market Size by Country
11.2.1 Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Contraceptives Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Contraceptives Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Contraceptives Value Chain Analysis
12.1.1 Contraceptives Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Contraceptives Production Mode & Process
12.2 Contraceptives Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Contraceptives Distributors
12.2.3 Contraceptives Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
